Micronesia (Federated States of) vs Tonga: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Micronesia (Federated States of)
0.6%
in 2024
Tonga
0.6%
in 2024
Micronesia (Federated States of) rank
60th
Tonga rank
60th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Micronesia (Federated States of)
- Tonga
How they compare
Micronesia (Federated States of) currently reports 0.6% against 0.6% in Tonga, a difference of 0.0%.
Across all 10 years both countries report, Tonga has been ahead every year.
Micronesia (Federated States of) ranks 60th and Tonga ranks 60th of 246 countries.
Tonga has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Micronesia (Federated States of) | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.9% | 1.1% | 0.1% | Tonga |
| 2020s | 0.6% | 0.7% | 0.1% | Tonga |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Micronesia (Federated States of) or Tonga?
- Micronesia (Federated States of), at 0.6% against 0.6% in Tonga as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Micronesia (Federated States of) and Tonga?
- 0.0%, with Micronesia (Federated States of) ahead.
- How many years of comparable data are there for Micronesia (Federated States of) and Tonga?
- 10 years are reported by both, from 2015 to 2024.
- How do Micronesia (Federated States of) and Tonga rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Micronesia (Federated States of) ranks 60th and Tonga ranks 60th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.